[1]马宏境,刘 彬.慢性阻塞性肺疾病发病机制的研究[J].医学信息,2019,32(10):50-52.[doi:10.3969/j.issn.1006-1959.2019.10.018]
　MA Hong-jing,LIU Bin.Study on the Pathogenesis of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(10):50-52.[doi:10.3969/j.issn.1006-1959.2019.10.018]
点击复制

慢性阻塞性肺疾病发病机制的研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年10期
页码:
50-52
栏目:
综述
出版日期:
2019-05-15

文章信息/Info

Title:
Study on the Pathogenesis of Chronic Obstructive Pulmonary Disease
文章编号:
1006-1959（2019）10-0050-03
作者:
马宏境1; 刘 彬2
（天津市第五中心医院呼吸科1，急诊科2，天津 300450）
Author(s):
MA Hong-jing1; LIU Bin2
(Department of Respiratory1,Department of Emergency Medicine2,Tianjin Fifth Central Hospital, Tianjin 300450,China)
关键词:
慢性阻塞性肺疾病; COPD; 呼吸系统; 发病机制
Keywords:
Chronic obstructive pulmonary disease; COPD; Respiratory system; Pathogenesis
分类号:
R563
DOI:
10.3969/j.issn.1006-1959.2019.10.018
文献标志码:
A
摘要:
慢性阻塞性肺疾病（COPD）在全球的发病率不断地上升，在我国发病率以及死亡率也居高不下，临床对于COPD的研究有很多，包括预防、诊断以及治疗等方面，很大程度上提高了人们对于COPD的认知。但是，目前对于COPD的发病机制尚无明确定论，公认的主要为炎症、蛋白酶-抗蛋白酶失衡以及氧化-抗氧化失衡这三种学说，但是近几年来，研究者在这三种发病机制有了更深的研究，也发现了新的可能的发病机制，本文将对此进行阐述，为COPD的诊治提供理论参考。
Abstract:
The incidence of chronic obstructive pulmonary disease (COPD) is increasing globally, and the incidence and mortality in China are also high. There are many clinical studies on COPD, including prevention, diagnosis and treatment. Increased awareness of COPD. However, there is no clear-cutting theory about the pathogenesis of COPD. It is generally recognized as the three theories of inflammation, protease-antiprotease imbalance and oxidative-antioxidative imbalance. However, in recent years, researchers have had these three pathogenesis mechanisms. Deeper research has also discovered new possible pathogenesis, which will be elaborated in this paper to provide a theoretical reference for the diagnosis and treatment of COPD.

参考文献/References:

[1]周先锋,阮晓楠,林涛,等.上海市浦东新区COPD患病率及其环境行为因素[J].现代预防医学,2018,45(22):4054-4058.
[2]祁玉诚,侯淑萍.慢性阻塞性肺疾病的流行病学调查及影响因素分析[J].中国现代药物应用,2017,11(4):77-79.
[3]杨素丽.血清炎性因子水平与慢性阻塞性肺疾病(COPD)患者肺功能相关性研究[J].药物生物技术,2018,25(6):500-503.
[4]陈智阳.C反应蛋白及降钙素原检测在慢性阻塞性肺疾病患者中的临床价值[J].医疗装备,2018,31(22):113-114.
[5]刘东兰.C反应蛋白和与白介素-6的检测在慢性阻塞性肺病治疗中的应用价值[J].当代医学,2016,22(29):39-40.
[6]张章国,张燕,李小燕,等.慢性阻塞性肺病患者血液前降钙素原、超敏C反应蛋白水平变化及其临床意义[J].中国卫生检验杂志,2016,26(8):1128-1130.
[7]李郝,周红艳.慢性阻塞性肺疾病急性加重期降钙素原与炎症因子的相关性分析[J].海南医学院学报,2014,20(3):347-349.
[8]蔡成森,王珺,李士涛,等.慢性阻塞性肺疾病发病机制中白细胞介素及相关基因调控的探讨[J].中华临床医师杂志(电子版),2015,9(16):3091-3095.
[9]钟萍,蒋雪莲,黄成亮,等.IL-6、IL-18、TWEAK与COPD稳定期患者营养状况的关系[J].广东医学,2018,6(39):1836-1840.
[10]高云,党建丽.慢性阻塞性肺疾病患者血清脂联素、瘦素、IL-8及8-异前列腺素 F2-ɑ水平与肺功能相关性的研究[J].临床肺科杂志,2018,23(11):2091-2096.
[11]Ghobadi H,Aslani MR,Hosseinian A,et al.The Correlation of Serum Brain Natriuretic Peptide and Interleukin-6 with Quality of Life Using the Chronic Obstructive Pulmonary Disease Assessment Test[J].Med Princ Pract,2018,26(6):509-515.
[12]Kim SW,Rhee CK,Kim KU,et al.Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease[J].Int J Chron Obstruct Pulmon Dis,2017(12):395-402.
[13]Mohan A,Sharma M,Uniyal A,et al.Variability in proteinase-antiproteinase balance, nutritional status,and quality of life in stable chronic obstructive pulmonary disease due to tobacco and nontobacco etiology[J].Lung India,2016,33(6):605-610.
[14]王嘉,孙武装,王鹏羽,等.慢性阻塞性肺疾病患者血清蛋白酶与抗蛋白酶的表达及意义[J].山东医药,2012,52(21):54-56.
[15]方庭正,欧敏.慢性阻塞性肺疾病的氧化/抗氧化失衡与抗氧化治疗[J].中国妇幼健康研究,2017,28(1):325-326.
[16]李秀娟,杨晓鹏,李德富,等.全真一气汤及其多糖对COPD模型小鼠肺组织氧化应激的影响[J].时珍国医国药,2017,28(8):1823-1826.
[17]蒋雪莲,钟萍,黄成亮,等.氧化应激反应标志物在慢性阻塞性肺疾病稳定期患者血清中的表达及意义[J].中国呼吸与危重监护杂志,2016,15(6):542-547.
[18]Barreiro E,Jaitovich A.Muscle atrophy in chronic obstructive pulmonary disease:molecular basis and potential therapeutic targets[J].J Thorac Dis,2018,10(12):S1415-S1424.
[19]Maltais F,Decramer M,Casaburi R,et al.An Official American Thoracic Society/European Respiratory Society Statement:Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease[J].Am J Respir Crit Care Med,2014,189(9):e15-e62.
[20]Gea J,Pascual S,Casadevall C,et al.Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings[J].J Thorac Dis,2015,7(10):E418-E438.
[21]Wang L,Hao K,Yang T,et al.Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease[J].Chin Med J,2017,130(17):2107-2111.
[22]Huang YJ,Sethi S,Murphy T,et al.Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease[J].J Clin Microbiol,2014,52(8):2813-2823.

相似文献/References:

[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
　ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(10):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
　CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(10):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
　WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Journal of Medical Information,2018,31(10):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
　LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(10):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]马建娟.布地奈德联合异丙托溴铵雾化治疗COPD 急性加重期的效果评价[J].医学信息,2018,31(07):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
　MA Jian-juan.Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD[J].Journal of Medical Information,2018,31(10):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
[7]任庆玲.聚焦解决模式对慢阻肺患者主要照顾者的 照顾负担及负性情绪影响的研究[J].医学信息,2018,31(07):162.[doi:10.3969/j.issn.1006-1959.2018.07.057]
　REN Qing-ling.Study on the Effect of Focus-resolving Model on the Burden of Care and Negative Emotions of Primary Caregivers in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(10):162.[doi:10.3969/j.issn.1006-1959.2018.07.057]
[8]罗 倩.COPD加重期患者肺功能、血气指标及 炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
　LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(10):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[9]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病 引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
　ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(10):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[10]刘 颖,杨志高,李慧琼,等.肠内联合肠外营养与肠内营养支持治疗COPD机械通气患者疗效比较的Meta分析[J].医学信息,2022,35(10):98.[doi:10.3969/j.issn.1006-1959.2022.10.024]
　LIU Ying,YANG Zhi-gao,LI Hui-qiong,et al.Meta-analysis of the Efficacy of Enteral Combined Parenteral Nutrition and Enteral Nutrition Support in the Treatment of COPD Patients with Mechanical Ventilation[J].Journal of Medical Information,2022,35(10):98.[doi:10.3969/j.issn.1006-1959.2022.10.024]

更新日期/Last Update: 2019-05-15